C07J 71/001
Oxiranes
Official title: {Oxiranes}
C07J71/001 (Oxiranes) appears on 386 US grants and 200 published applications in this corpus.
Search patents in C07J- Granted patents
- 386
- Published applications
- 200
- Assignees
- 179
- Inventors
- 737
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 11 | 0 |
| 1978 | 18 | 0 |
| 1979 | 8 | 0 |
| 1980 | 16 | 0 |
| 1981 | 10 | 0 |
| 1982 | 12 | 0 |
| 1983 | 6 | 0 |
| 1984 | 9 | 0 |
| 1985 | 9 | 0 |
| 1986 | 11 | 0 |
| 1987 | 7 | 0 |
| 1988 | 5 | 0 |
| 1989 | 11 | 0 |
| 1990 | 19 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 12 | 0 |
| 1994 | 6 | 0 |
| 1995 | 10 | 0 |
| 1996 | 8 | 0 |
| 1997 | 18 | 0 |
| 1998 | 15 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 0 |
| 2002 | 4 | 10 |
| 2003 | 5 | 10 |
| 2004 | 7 | 12 |
| 2005 | 7 | 8 |
| 2006 | 5 | 6 |
| 2007 | 4 | 5 |
| 2008 | 2 | 1 |
| 2009 | 0 | 4 |
| 2010 | 3 | 4 |
| 2011 | 1 | 6 |
| 2012 | 1 | 3 |
| 2013 | 2 | 8 |
| 2014 | 4 | 8 |
| 2015 | 6 | 5 |
| 2016 | 7 | 12 |
| 2017 | 7 | 15 |
| 2018 | 7 | 6 |
| 2019 | 14 | 15 |
| 2020 | 14 | 15 |
| 2021 | 9 | 18 |
| 2022 | 6 | 6 |
| 2023 | 3 | 7 |
| 2024 | 4 | 7 |
| 2025 | 2 | 6 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Steroidal compositions and methods of treating lipogenic cancers28 Oct 2025US 12,454,547 B2Asteroid Therapeutics
- Farnesoid X receptor modulators6 May 2025US 12,291,549 B2Intercept Pharmaceuticals, Inc.
- Steroid derivative regulators, method for preparing the same, and uses thereof12 Nov 2024US 12,139,508 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Compositions and methods for treating CNS disorders20 Aug 2024US 12,065,463 B2Sage Therapeutics, Inc.
- 17-beta-hydroxywithanolides and use thereof in treating cancer25 Jun 2024US 12,018,045 B2Arizona Board of Regents on Behalf of the University of Arizona
- 25-hydroxy-cholest-5-en-3-sulfate choline, formulations thereof and methods for preparing, and uses of same23 Jul 2026US 2026/0207628 A1Durect Corporation
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116911 A1Sage Therapeutics, Inc.
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116912 A1Sage Therapeutics, Inc.
- Farnesoid x receptor modulators11 Dec 2025US 2025/0376488 A1
- Neuroactive steroids and compositions thereof7 Aug 2025US 2025/0250296 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Androstane carbothioates130US 4,335,121 AGlaxo Group Limited · 1982
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- vitamin D.sub.3 derivatives having a substituent at 2-position96US 4,666,634 AChugai Seiyaku Kabushiki Kaisha · 1987
- 19-Oxygenated-5.alpha.-androstanes for the enhancement of libido91US 4,071,625 ARichardson-Merrell Inc. · 1978
- 17-Hydroxy-steroids72US 4,898,694 A1990